From Bio Co.,Ltd (KOSDAQ:377220)
South Korea
· Delayed Price · Currency is KRW 2,190.00
+50.00 (2.34%)
At close: May 8, 2025, 3:30 PM KST
From Bio Co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Operating Revenue | 67,182 | 66,724 | 99,330 | 135,103 |
| Other Revenue | - | - | -0 | -0 |
| Revenue | 67,182 | 66,724 | 99,330 | 135,103 |
| Revenue Growth (YoY) | 0.69% | -32.83% | -26.48% | - |
| Cost of Revenue | 30,036 | 20,769 | 30,022 | 32,999 |
| Gross Profit | 37,145 | 45,955 | 69,309 | 102,104 |
| Selling, General & Admin | 60,199 | 60,432 | 67,684 | 90,018 |
| Operating Expenses | 61,416 | 61,375 | 68,412 | 90,680 |
| Operating Income | -24,271 | -15,420 | 897.02 | 11,424 |
| Interest Expense | -1,015 | -188.65 | -13.78 | -24.7 |
| Interest & Investment Income | 184.14 | 336.08 | 732.91 | 223.72 |
| Currency Exchange Gain (Loss) | 19.9 | -82.46 | 95.15 | 123.06 |
| Other Non Operating Income (Expenses) | -88.01 | -519.78 | -196.06 | -92.79 |
| EBT Excluding Unusual Items | -25,170 | -15,875 | 1,515 | 11,653 |
| Gain (Loss) on Sale of Investments | -85.98 | 125.03 | -0.06 | -2.84 |
| Gain (Loss) on Sale of Assets | 364 | 9.84 | -2.8 | -12.09 |
| Pretax Income | -24,892 | -15,740 | 1,512 | 11,638 |
| Income Tax Expense | 1,338 | -4,131 | 194.37 | 355.96 |
| Earnings From Continuing Operations | -26,230 | -11,609 | 1,318 | 11,282 |
| Minority Interest in Earnings | 942.32 | 533 | 1,923 | - |
| Net Income | -25,288 | -11,076 | 3,241 | 11,282 |
| Net Income to Common | -25,288 | -11,076 | 3,241 | 11,282 |
| Net Income Growth | - | - | -71.28% | - |
| Shares Outstanding (Basic) | 28 | 28 | 28 | 24 |
| Shares Outstanding (Diluted) | 28 | 28 | 28 | 24 |
| Shares Change (YoY) | - | - | 15.58% | - |
| EPS (Basic) | -893.26 | -391.25 | 114.47 | 460.62 |
| EPS (Diluted) | -893.26 | -391.25 | 114.00 | 460.62 |
| EPS Growth | - | - | -75.25% | - |
| Free Cash Flow | -15,593 | -37,501 | -15,613 | -9,956 |
| Free Cash Flow Per Share | -550.81 | -1324.66 | -551.49 | -406.47 |
| Gross Margin | 55.29% | 68.87% | 69.78% | 75.58% |
| Operating Margin | -36.13% | -23.11% | 0.90% | 8.46% |
| Profit Margin | -37.64% | -16.60% | 3.26% | 8.35% |
| Free Cash Flow Margin | -23.21% | -56.20% | -15.72% | -7.37% |
| EBITDA | -21,976 | -13,775 | 2,039 | 12,496 |
| EBITDA Margin | -32.71% | -20.64% | 2.05% | 9.25% |
| D&A For EBITDA | 2,295 | 1,645 | 1,142 | 1,072 |
| EBIT | -24,271 | -15,420 | 897.02 | 11,424 |
| EBIT Margin | -36.13% | -23.11% | 0.90% | 8.46% |
| Effective Tax Rate | - | - | 12.85% | 3.06% |
| Advertising Expenses | 17,861 | 17,997 | 23,875 | 29,357 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.